Trottier B - Search Results

1

Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.

Ogbuagu O, Segal-Maurer S, Ratanasuwan W, Avihingsanon A, Brinson C, Workowski K, Antinori A, Yazdanpanah Y, Trottier B, Wang H, Margot N, Dvory-Sobol H, Rhee MS, Baeten JM, Molina JM; GS-US-200-4625 investigators. Ogbuagu O, et al. Among authors: trottier b. Lancet HIV. 2023 Aug;10(8):e497-e505. doi: 10.1016/S2352-3018(23)00113-3. Epub 2023 Jul 11. Lancet HIV. 2023. PMID: 37451297 Clinical Trial.

2

Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV): design and methods for a randomised controlled trial.

Laurie C, El-Zein M, Tota J, Tellier PP, Coutlée F, Franco EL, de Pokomandy A; LIMIT-HPV study group. Laurie C, et al. BMJ Open. 2020 Mar 23;10(3):e035113. doi: 10.1136/bmjopen-2019-035113. BMJ Open. 2020. PMID: 32205376 Free PMC article.

3

IL-10 and lymphotoxin-α expression profiles within marginal zone-like B-cell populations are associated with control of HIV-1 disease progression.

Chagnon-Choquet J, Fontaine J, Poudrier J, Roger M; Montreal Primary HIV Infection Study Group; Slow Progressor Study Group. Chagnon-Choquet J, et al. PLoS One. 2014 Jul 8;9(7):e101949. doi: 10.1371/journal.pone.0101949. eCollection 2014. PLoS One. 2014. PMID: 25003989 Free PMC article.

4

Prevalence and Characterization of Subclinical Coronary Atherosclerotic Plaque with CT among Individuals with HIV: Results from the Canadian HIV and Aging Cohort Study.

Boldeanu I, Sadouni M, Mansour S, Baril JG, Trottier B, Soulez G, S Chin A, Leipsic J, Tremblay C, Durand M, Chartrand-Lefebvre C; Canadian HIV and Aging Cohort Study Group. Boldeanu I, et al. Among authors: trottier b. Radiology. 2021 Jun;299(3):571-580. doi: 10.1148/radiol.2021203297. Epub 2021 Apr 20. Radiology. 2021. PMID: 33876969

5

HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.

Tremblay C, Hardy I, Lalonde R, Trottier B, Tsarevsky I, Vézina LP, Roger M, Wainberg M, Baril JG. Tremblay C, et al. Among authors: trottier b. Can J Infect Dis Med Microbiol. 2013 Winter;24(4):202-8. doi: 10.1155/2013/982759. Can J Infect Dis Med Microbiol. 2013. PMID: 24489562 Free PMC article.

6

Acute renal failure in four HIV-infected patients: Potential association with tenofovir and nonsteroidal anti-inflammatory drugs.

Bpharm SM, Talbot A, Trottier B. Bpharm SM, et al. Among authors: trottier b. Can J Infect Dis Med Microbiol. 2008 Jan;19(1):75-6. doi: 10.1155/2008/370535. Can J Infect Dis Med Microbiol. 2008. PMID: 19145267 Free PMC article. No abstract available.

7

Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal.

Routy JP, Machouf N, Edwardes MD, Brenner BG, Thomas R, Trottier B, Rouleau D, Tremblay CL, Côté P, Baril JG, Remis RS, Sékaly RP, Wainberg MA. Routy JP, et al. Among authors: trottier b. AIDS. 2004 Nov 19;18(17):2305-12. doi: 10.1097/00002030-200411190-00011. AIDS. 2004. PMID: 15577543

8

Maraviroc for previously treated patients with R5 HIV-1 infection.

Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams. Gulick RM, et al. N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152. N Engl J Med. 2008. PMID: 18832244 Free PMC article. Clinical Trial.

9

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.

Katlama C, Haubrich R, Lalezari J, Lazzarin A, Madruga JV, Molina JM, Schechter M, Peeters M, Picchio G, Vingerhoets J, Woodfall B, De Smedt G; DUET-1, DUET-2 study groups. Katlama C, et al. AIDS. 2009 Nov 13;23(17):2289-300. doi: 10.1097/QAD.0b013e3283316a5e. AIDS. 2009. PMID: 19710593 Clinical Trial.

10

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials.

Katlama C, Clotet B, Mills A, Trottier B, Molina JM, Grinsztejn B, Towner W, Haubrich R, Nijs S, Vingerhoets J, Woodfall B, Witek J. Katlama C, et al. Among authors: trottier b. Antivir Ther. 2010;15(7):1045-52. doi: 10.3851/IMP1662. Antivir Ther. 2010. PMID: 21041921 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page